Arkolith/Insider Trading/CGEM/Form 4

Nichols Weston

10% OwnerCullinan Therapeutics, Inc. (CGEM) · full profile →Form 4 · filed Oct 30, 2025
Net Buying
Open-Market Buys
$1.4M
Open-Market Sells
$0
Net Open-Market Flow
$1.4M
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 28, 2025Buy(P)166K$8.40$1.4M9.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000902664-25-004662) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML